Stephen F. Hobbiger

3.6k total citations
5 papers, 187 citations indexed

About

Stephen F. Hobbiger is a scholar working on Epidemiology, Economics and Econometrics and Pharmacology. According to data from OpenAlex, Stephen F. Hobbiger has authored 5 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Epidemiology, 2 papers in Economics and Econometrics and 1 paper in Pharmacology. Recurrent topics in Stephen F. Hobbiger's work include Health Systems, Economic Evaluations, Quality of Life (2 papers), Acute Ischemic Stroke Management (2 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). Stephen F. Hobbiger is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (2 papers), Acute Ischemic Stroke Management (2 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). Stephen F. Hobbiger collaborates with scholars based in United Kingdom, Netherlands and Italy. Stephen F. Hobbiger's co-authors include Martin W. Lunnon, Kennedy R. Lees, Keith W. Muir, Steven Hamilton, Christine E. Hallgreen, Torbjörn Callréus, Georgy Genov, Davide Luciani, Lawrence D. Phillips and George Quartey and has published in prestigious journals such as Annals of the New York Academy of Sciences, British Journal of Clinical Pharmacology and Cerebrovascular Diseases.

In The Last Decade

Stephen F. Hobbiger

5 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen F. Hobbiger United Kingdom	5	64	34	31	29	22	5	187
А. В. Зилов Russia	8	24 0.4×	21 0.6×	33 1.1×	10 0.3×	72 3.3×	35	325
K. Piwernetz Germany	7	10 0.2×	31 0.9×	47 1.5×	17 0.6×	33 1.5×	22	266
Fei-Na Chen Taiwan	9	47 0.7×	16 0.5×	34 1.1×	15 0.5×	60 2.7×	13	352
P Moleur France	8	48 0.8×	197 5.8×	20 0.6×	5 0.2×	23 1.0×	14	315
Rita Gangwani Hong Kong	15	32 0.5×	16 0.5×	73 2.4×	12 0.4×	26 1.2×	26	493
Konstantinos Pateras Greece	12	28 0.4×	191 5.6×	47 1.5×	11 0.4×	24 1.1×	34	359
Siin Kim South Korea	8	22 0.3×	47 1.4×	26 0.8×	6 0.2×	33 1.5×	28	293
Naveed Younis United Kingdom	11	15 0.2×	74 2.2×	34 1.1×	46 1.6×	51 2.3×	19	456
Paulo Carita France	9	55 0.9×	113 3.3×	8 0.3×	62 2.1×	28 1.3×	23	350
Desmond Kenny Ireland	11	29 0.5×	7 0.2×	42 1.4×	10 0.3×	25 1.1×	18	328

Countries citing papers authored by Stephen F. Hobbiger

Since Specialization

Citations

This map shows the geographic impact of Stephen F. Hobbiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen F. Hobbiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen F. Hobbiger more than expected).

Fields of papers citing papers by Stephen F. Hobbiger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen F. Hobbiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen F. Hobbiger. The network helps show where Stephen F. Hobbiger may publish in the future.

Co-authorship network of co-authors of Stephen F. Hobbiger

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen F. Hobbiger. A scholar is included among the top collaborators of Stephen F. Hobbiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen F. Hobbiger. Stephen F. Hobbiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Mt‐Isa, Shahrul, Christine E. Hallgreen, Nan Wang, et al.. (2014). Balancing benefit and risk of medicines: a systematic review and classification of available methodologies. Pharmacoepidemiology and Drug Safety. 23(7). 667–678. 89 indexed citations

2.

Muir, Keith W., Steven Hamilton, Martin W. Lunnon, Stephen F. Hobbiger, & Kennedy R. Lees. (1998). Safety and Tolerability of 619C89 after Acute Stroke. Cerebrovascular Diseases. 8(1). 31–37. 65 indexed citations

3.

Hussein, Ziad, Kennedy R. Lees, K.W. Muir, et al.. (1996). Pharmacokinetics of 619C89, a novel neuronal sodium channel inhibitor, in acute stroke patients after loading and discrete maintenance infusions. British Journal of Clinical Pharmacology. 41(6). 505–511. 10 indexed citations

4.

Muir, Keith W., Kennedy R. Lees, Steven Hamilton, et al.. (1995). A Randomized, Double‐Blind, Placebo‐Controlled Ascending Dose Tolerance Study of 619C89 in Acute Stroke. Annals of the New York Academy of Sciences. 765(1). 328–329. 17 indexed citations

5.

Lamb, R. J., et al.. (1995). The Tolerability, Pharmacokinetics and Pharmacodynamics of Increasing Intravenous Doses of 619C89, a Novel Compound for the Acute Treatment of Stroke, in Healthy Volunteers. Annals of the New York Academy of Sciences. 765(1). 324–326. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact